Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02643238 · ClinicalTrials.gov registry record · NA
Continued Study of Artificial Vision: Evaluation of the BrainPort® System and Investigation of Visual Ambulation
A NA study, sponsored by Akron Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT02643238: Completed NA study, sponsored by Akron Children's Hospital.
NCT02643238 is a NA study that has completed, run by Akron Children's Hospital. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02643238, a NA study, has completed, sponsored by Akron Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the use of an artificial vision system called Brainport system in blind patients To investigate visual, and oculomotor (eye motion) mechanisms involved in the use of the Brainport system.
Primary Outcome
To evaluate the usefulness of an artificial vision system called BrainPort® system in blind patients
Interventions
- DEVICE BrainPort
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2011-10 |
| Est. Completion | 2022-05 |
| Phase | NA |
What the finished NCT02643238 record still lists
NCT02643238 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which BrainPort is the first listed.
NCT02643238 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02643238 about?
NCT02643238 is a clinical study titled "Continued Study of Artificial Vision: Evaluation of the BrainPort® System and Investigation of Visual Ambulation". The purpose of this study is to evaluate the use of an artificial vision system called Brainport system in blind patients To investigate visual, and oculomotor (eye motion) mechanisms involved in the use of the Brainport system.
What is the current status of trial NCT02643238?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2011-10. Estimated completion is 2022-05.
What interventions are being tested in trial NCT02643238?
The interventions under investigation include: BrainPort (DEVICE).
Who is sponsoring clinical trial NCT02643238?
This trial is sponsored by Akron Children's Hospital, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02643238's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia